Edition:
United Kingdom

Meridian Bioscience Inc (VIVO.OQ)

VIVO.OQ on NASDAQ Stock Exchange Global Select Market

17.53USD
18 Dec 2018
Change (% chg)

$0.18 (+1.04%)
Prev Close
$17.35
Open
$17.53
Day's High
$17.93
Day's Low
$17.43
Volume
83,341
Avg. Vol
83,414
52-wk High
$19.82
52-wk Low
$13.68

Select another date:

Fri, Nov 30 2018

FDA approves Meridian Bioscience's test for herpes in newborns

The U.S. Food and Drug Administration approved on Friday the first test - a diagnostic from Meridian Bioscience Inc - to help detect a type of herpes virus in newborns.

UPDATE 1-FDA approves Meridian Bioscience's test for herpes in newborns

Nov 30 The U.S. Food and Drug Administration approved on Friday the first test - a diagnostic from Meridian Bioscience Inc - to help detect a type of herpes virus in newborns.

FDA approves Meridian Bioscience's diagnostic for herpes in newborns

Nov 30 The U.S. Food and Drug Administration approved on Friday a diagnostic test from Meridian Bioscience Inc as the first tool to help detect a type of herpes virus in newborns.

Select another date: